Thursday, February 03, 2022 9:37:31 PM
I don't know if its the only investigative pathway--but it is the OBVIOUS one--enter the Occam Razor
You leave out the millions $$ that nodder pocketed from amarex kickbacks, and the fife kickbacks
Its funny some shareholders have always wondered--why would a CEO continue to use toxic financing--why not just sell the shares that shareholders alklowed to be used for funds?? Why get 6- 70 cents for each dollar and throw in warrants on top of that?? Well its not hard to figure out if anyone tries. Same with amarex. Some shareholders were grumbling in 2018 and a lot in 2019 that "something is wrong" with the CRO and the BLA not being filed and NO ONE @ cydy demanding an audit? No outside consultant to check data? Can you imagine ANY company that spent MILLIONS for data--not wanting that data verified--FOR YEARS. All along being lied to about "they do fantastic job".
Then suddenly when the cheating CFO is retired--the new (complicit in scheme) CFO suddenly finds accounting mistakes--oh look what I found!! Only going on for a few years. Good job Judas--I mean Antonio
Now question is why have skelly and antonio been allowed to remain??
You leave out the millions $$ that nodder pocketed from amarex kickbacks, and the fife kickbacks
Its funny some shareholders have always wondered--why would a CEO continue to use toxic financing--why not just sell the shares that shareholders alklowed to be used for funds?? Why get 6- 70 cents for each dollar and throw in warrants on top of that?? Well its not hard to figure out if anyone tries. Same with amarex. Some shareholders were grumbling in 2018 and a lot in 2019 that "something is wrong" with the CRO and the BLA not being filed and NO ONE @ cydy demanding an audit? No outside consultant to check data? Can you imagine ANY company that spent MILLIONS for data--not wanting that data verified--FOR YEARS. All along being lied to about "they do fantastic job".
Then suddenly when the cheating CFO is retired--the new (complicit in scheme) CFO suddenly finds accounting mistakes--oh look what I found!! Only going on for a few years. Good job Judas--I mean Antonio
Now question is why have skelly and antonio been allowed to remain??
Recent CYDY News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/21/2026 04:15:12 AM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 05/20/2026 09:08:39 PM
- CytoDyn to Present at the LD Micro Invitational XVI • GlobeNewswire Inc. • 05/15/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 08:32:50 PM
- CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer • GlobeNewswire Inc. • 04/27/2026 12:30:00 PM
- CytoDyn to Host Investor Webcast • GlobeNewswire Inc. • 04/23/2026 12:30:00 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 04/22/2026 09:21:50 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Colorectal Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/22/2026 12:30:00 PM
- CytoDyn Completes Enrollment in Phase 2 Metastatic Colorectal Cancer Study • GlobeNewswire Inc. • 04/21/2026 08:10:00 PM
- CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/20/2026 12:30:00 PM
- CytoDyn to Present at the AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/14/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/08/2026 09:15:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/08/2026 12:30:28 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/25/2026 09:16:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:24:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:22:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:21:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/24/2026 09:20:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 09:15:24 PM
- CytoDyn Presents at AACR Special Conference in Cancer Research: Brain Cancer • GlobeNewswire Inc. • 03/24/2026 12:30:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 03/09/2026 09:15:18 PM
